Chemotherapy Related Content

Only half of patients with colorectal and endometrial cancer respond to immunotherapy, which is designed to recognise and attack cancer cells

NHS cancer patients will be the first to experience drone chemotherapy, which furthers the NHS net zero strategy, as it cuts down travel time and distance.

Scientists have began using trametinib – used to treat skin and lung cancers – for ovarian cancer, showing that it can significantly slow the progression of the cancer.

Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.

Researchers from the University of Western Australia have found that the venom of honeybees can destroy aggressive breast cancer cells in a lab setting.

The National Institute for Health and Care Excellence (NICE) said they need more research into CBD medicines before the NHS can prescribe them in general.

Christian Siebel and Dott.ssa Bianca Posocco detail the work of DIACHEMO, a Euroepan project developing a platform technology for point-of-care devices for chemotherapeutics and other drugs.

Data from Public Health England shows that cancer diagnosis could impact upon which kind of treatment a patient receives.

Bethany Torr, campaigns and advocacy officer at Leukaemia Care discusses the impact of chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML) on patients

The need for supportive care in oncology will increase as patients continue to live longer and cancer progresses to become more like a chronic disease Supportive care increases patient quality of life, improves their chances of completing treatment, can reduce costs for healthcare institutions, and is fundamentally necessary given that...

Professor Jatinder Lamba from the Department of Pharmacotherapy and Translational Research gives an in-depth perspective on acute myeloid leukaemia (AML) and cytarabine pharmacogenomics Acute myeloid leukaemia (AML) is the cancer of the myeloid precursor stem cells character­ised by the appearance of immature, abnormal myeloid cells in bone marrow and other...

Acute myeloid leukaemia (AML), a form of blood cancer is placed into the spotlight by Open Access Government Acute myeloid leukaemia (AML) is a form of blood cancer, which affects the white blood cells known as myeloid cells. It is a rapidly progressing form of leukaemia. Blood cells are formed...

Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease Leukaemia’ is an umbrella term for cancers of the white blood cells – ‘leuk’ means white and ‘aemia’ refers to a condition of the blood. 26 people are...

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Ivan Stamenkovic, professor of experimental pathology at the University of Lausanne underlines research taking place around cancer progression Cancer progression, meaning the evolution of localised tumour growth to an invasion of adjacent tissue and dissemination to distant organs is a complex process that is intimately related to interactions between tumour...